Literature DB >> 21994039

Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.

Paola Scaruffi1, Fabio Morandi, Fabio Gallo, Sara Stigliani, Stefano Parodi, Stefano Moretti, Stefano Bonassi, Paolo Fardin, Alberto Garaventa, Giulio Zanazzo, Vito Pistoia, Gian Paolo Tonini, Maria Valeria Corrias.   

Abstract

BACKGROUND: At diagnosis, children with neuroblastoma (NB) present with either localized or metastatic disease. Since the mechanisms responsible for BM invasion are not well known, we investigated the transcriptome of resident BM cells from NB patients as compared to healthy children. PROCEDURE: Ninety-two and 88 children with localized and metastatic NB, respectively, and 15 healthy children were included in the study. BM resident cells recovered from BM aspirates by immunomagnetic bead manipulation were subjected to genome-wide microarray analysis. After validation in an independent set of samples, the genes significantly modulated in resident BM cells from NB patients were tested for their diagnostic/prognostic values.
RESULTS: BM resident cells, irrespective of neoplastic cell invasion, significantly overexpressed genes involved in innate immune responses, and interferon (IFN) and IFN-DRS signatures were enriched. Genes coding for metallothioneins and zinc finger proteins, and involved in histone and nucleosome/chromatin organization were also overexpressed. Resident BM cells from NB patients significantly downregulated genes involved in cell adhesion, and in erythrocyte, myeloid, and platelet differentiation pathways. Among downregulated genes, CXCL12 expression reached near complete silencing in patients with metastatic disease. The downregulation of CXCL12 expression was independent of contact between NB cell and resident BM cell.
CONCLUSIONS: We demonstrated that NB tumor growth at the primary site can alter the BM microenvironment, and the presence of BM-infiltrating NB cells makes the alterations more pronounced. Therefore, the restoration of a BM physiological state by means of IFN-α monoclonal antibody, Sifalimumab, and selective noradrenaline receptor blockers should be further studied to ameliorate patients' clinical management.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21994039     DOI: 10.1002/pbc.23339

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  13 in total

Review 1.  Zinc and zinc-containing biomolecules in childhood brain tumors.

Authors:  Jan Hrabeta; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Sona Krizkova; Vojtech Adam
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

2.  Novel pharmacodynamic biomarkers for MYCN protein and PI3K/AKT/mTOR pathway signaling in children with neuroblastoma.

Authors:  Jennifer R Smith; Lucas Moreno; Simon P Heaton; Louis Chesler; Andrew D J Pearson; Michelle D Garrett
Journal:  Mol Oncol       Date:  2015-11-19       Impact factor: 6.603

3.  CD4+CD25hiCD127- Treg and CD4+CD45R0+CD49b+LAG3+ Tr1 cells in bone marrow and peripheral blood samples from children with neuroblastoma.

Authors:  Fabio Morandi; Sarah Pozzi; Sebastiano Barco; Giuliana Cangemi; Loredana Amoroso; Barbara Carlini; Vito Pistoia; Maria Valeria Corrias
Journal:  Oncoimmunology       Date:  2016-10-24       Impact factor: 8.110

4.  Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma.

Authors:  Fabio Morandi; Loredana Amoroso; Alessandra Dondero; Roberta Castriconi; Stefano Parodi; Roberto Luksch; Fiorina Casale; Aurora Castellano; Alberto Garaventa; Alessandro Moretta; Cristina Bottino; Mirco Ponzoni; Maria Valeria Corrias
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110

5.  Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins.

Authors:  Fabio Morandi; Paola Scaruffi; Fabio Gallo; Sara Stigliani; Stefano Moretti; Stefano Bonassi; Claudio Gambini; Katia Mazzocco; Paolo Fardin; Riccardo Haupt; Giampaolo Arcamone; Vito Pistoia; Gian Paolo Tonini; Maria Valeria Corrias
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

6.  Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.

Authors:  Sara Stigliani; Paola Scaruffi; Corrado Lagazio; Luca Persico; Barbara Carlini; Luigi Varesio; Fabio Morandi; Martina Morini; Anna Rita Gigliotti; Maria Rosaria Esposito; Elisabetta Viscardi; Valerio Cecinati; Massimo Conte; Maria Valeria Corrias
Journal:  Oncotarget       Date:  2015-05-30

Review 7.  Trial Watch: Immunostimulatory cytokines.

Authors:  Erika Vacchelli; Alexander Eggermont; Wolf Hervé Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-05-07       Impact factor: 8.110

8.  Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma.

Authors:  Aamir Zainulabadeen; Philip Yao; Habil Zare
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

Review 9.  Bone Marrow Environment in Metastatic Neuroblastoma.

Authors:  Chiara Brignole; Fabio Pastorino; Patrizia Perri; Loredana Amoroso; Veronica Bensa; Enzo Calarco; Mirco Ponzoni; Maria Valeria Corrias
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

10.  Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma.

Authors:  Fabio Morandi; Sebastiano Barco; Sara Stigliani; Michela Croce; Luca Persico; Corrado Lagazio; Francesca Scuderi; Maria Luisa Belli; Mariapina Montera; Giuliana Cangemi; Sarah Pozzi; Valentina Rigo; Paola Scaruffi; Loredana Amoroso; Giovanni Erminio; Vito Pistoia; Silvano Ferrini; Maria Valeria Corrias
Journal:  Oncotarget       Date:  2017-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.